SKIN INVESTOR ALERT

Robbins Geller Rudman & Dowd LLP Announces that The Beauty Health Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of The Beauty Health Company (NASDAQ: SKIN) securities between May 10, 2022 and November 13, 2023, inclusive (the “Class Period”), have until January 16, 2024 to seek appointment as lead plaintiff of the Beauty Health class action lawsuit. Captioned Alghazwi v. The Beauty Health Company, No. 23-cv-09733 (C.D. Cal.), the Beauty Health class action lawsuit charges Beauty Health and certain of its top current and former executive officers with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Beauty Health class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-the-beauty-health-company-class-action-l ...

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [e-mail].

CASE ALLEGATIONS: Beauty Health is a health and beauty company which provides “skin health experiences.”

The Beauty Health class action lawsuit alleges that defendants throughout the Class Period failed to disclose that: (i) Syndeo 1.0 and 2.0 devices had issues leading to “frequent treatment interruptions”; (ii) as a result, Beauty Health incurred significant costs to develop enhancements; (iii) despite the enhancements, providers continued to experience issues with the Syndeo devices; (iv) consequently, Beauty Health would no longer market Syndeo 1.0 and 2.0 devices and incur significant inventory write-downs; and (v) as such, Beauty Health’s profitability would be adversely impacted.

The Beauty Health class action lawsuit further alleges that on August 9, 2023, Beauty Health announced that its second quarter of 2023 gross margin was “unfavorably impacted” by a mix shift “toward lower-margin refurbished devices . . . as U.S. providers awaited Syndeo enhancements in the third quarter [of] 2023 to improve user experience.” Beauty Health also announced the “involuntary separation without cause” of Beauty Health’s Chief Financial Officer, defendant Liyuan Woo, the Beauty Health class action lawsuit also alleges. On this news, the price of Beauty Health shares fell by more than 5%, the complaint alleges.